RecruitingNot ApplicableNCT06148883

Management of Patients With New Left Bundle Branch Block After Transcatheter Aortic Valve Implantation

Comparison of Early Ambulatory Monitoring Strategy Versus Electrophysiological Study Approach in the Management of Patients With New Left Bundle Branch Block After Transcatheter Aortic Valve Implantation


Sponsor

Assistance Publique Hopitaux De Marseille

Enrollment

360 participants

Start Date

Nov 12, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to show that Electrocardiogram Ambulatory Monitoring-guided strategy is superior to ElectroPhysiological Study on the rate of alive patients with an appropriate Pacemaker implantation/non-implantation, at 12 months after randomization, in patients with New Onset Persistent Left Bundle Branch Block after Transcatheter Aortic Valve Implantation.


Eligibility

Min Age: 18 Years

Inclusion Criteria17

  • Patients who are 18 years or older and undergo Transcatheter Aortic Valve Implantation :
  • Presenting with New Onset Persistent Left Bundle Branch Block, defined as a new Left Bundle Branch Block \>150 ms that persists at least two days after Transcatheter Aortic Valve Implantation and is stable
  • With an anticipated life expectancy \>1 year
  • Who consent to participate to the study
  • Documented high grade Atrio Ventricular block (Atrio Ventricular block of a degree higher than Mobitz I)
  • Persistent PR interval prolongation \> 240 ms
  • Occurrence of syncope or sudden cardiac death,
  • Identification of any indisputable criteria for Pacemaker implantation
  • Definitive Pacemaker implantation
  • Prior Pacemaker or Implantable Cardiac defibrillator
  • Indication for Cardiac Resynchronization Therapy or Implantable cardiac defibrillator
  • Pre-existing Left Bundle Branch Block or Right Bundle Branch Block
  • Pre-existing PR interval prolongation \> 240 ms
  • Severe or moderate dementia, evaluated before Transcatheter Aortic Valve Implantation, defined as a Mini Mental State Examination \< 15
  • Pregnancy or breastfeeding patient
  • No affiliation to a social security scheme
  • Adult under legal protection (trusteeship, guardianship).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETranscatheter Aortic Valve Implantation

Transcatheter Aortic Valve Implantation is the implantation of a biological aortic valve percutaneously


Locations(1)

Hôpital de la Timone - APHM

Marseille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06148883


Related Trials